COVID-19: A novel strain challenging the human race

V. Ranganathan, Padma Madham, Arpitha Somayaji
{"title":"COVID-19: A novel strain challenging the human race","authors":"V. Ranganathan, Padma Madham, Arpitha Somayaji","doi":"10.15406/JMEN.2020.08.00292","DOIUrl":null,"url":null,"abstract":"Diseases are not new to the humans’ as we have learnt to cope up with a variety of contagion and contagious infections. Way back in the 18 th century cowpox was a terrorizing clinical condition and as time progressed, the era of rabies and TB was an issue of health concern. But time has been the eternal evidence to validate the fight of mankind against these clinical manifestations. However, over the last few months, the world is being taken by a swing by an invisible, nanoscopic biological particle which was later named as COVID-19 or in short form is represented as nCoV-19 where n designate the uniqueness of the virus and is rightly called as novel corona virus 19 (nCoV-19). Though the outbreak of the pandemic gained its pace in 2020, it was initially discovered in December 2019 in the Wuhan province of China. Hence the virus is represented with 19 as a suffix. The disease which initially started as an epidemic soon started its universal form and became a severe pandemic all over the globe. The current article is an attempt to comprehend the facets of COVID-19 otherwise called as novel corona virus which is very often compared to the SARS outbreak in 2002 in China. The article also attempts to disclose various measures undertaken by the government and private firms to curb the intensity of the contagion. The current article emphasizes on clinical signs and epidemiological characteristics of novel corona virus disease and endeavors to brief out the possible steps to curd the rapid spreading of the disease.","PeriodicalId":91326,"journal":{"name":"Journal of microbiology & experimentation","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of microbiology & experimentation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/JMEN.2020.08.00292","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Diseases are not new to the humans’ as we have learnt to cope up with a variety of contagion and contagious infections. Way back in the 18 th century cowpox was a terrorizing clinical condition and as time progressed, the era of rabies and TB was an issue of health concern. But time has been the eternal evidence to validate the fight of mankind against these clinical manifestations. However, over the last few months, the world is being taken by a swing by an invisible, nanoscopic biological particle which was later named as COVID-19 or in short form is represented as nCoV-19 where n designate the uniqueness of the virus and is rightly called as novel corona virus 19 (nCoV-19). Though the outbreak of the pandemic gained its pace in 2020, it was initially discovered in December 2019 in the Wuhan province of China. Hence the virus is represented with 19 as a suffix. The disease which initially started as an epidemic soon started its universal form and became a severe pandemic all over the globe. The current article is an attempt to comprehend the facets of COVID-19 otherwise called as novel corona virus which is very often compared to the SARS outbreak in 2002 in China. The article also attempts to disclose various measures undertaken by the government and private firms to curb the intensity of the contagion. The current article emphasizes on clinical signs and epidemiological characteristics of novel corona virus disease and endeavors to brief out the possible steps to curd the rapid spreading of the disease.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19:一种挑战人类的新型病毒
疾病对人类来说并不新鲜,因为我们已经学会了应对各种传染病和传染性感染。早在18世纪,牛痘是一种可怕的临床疾病,随着时间的推移,狂犬病和结核病的时代成为一个健康问题。但时间是永恒的证据,证明人类与这些临床表现的斗争是正确的。然而,在过去的几个月里,世界正被一种看不见的纳米级生物颗粒所动摇,这种颗粒后来被命名为COVID-19,或者简称为nCoV-19,其中n表示该病毒的独特性,并被正确地称为新型冠状病毒19 (nCoV-19)。尽管疫情在2020年加速爆发,但它最初是在2019年12月在中国武汉市被发现的。因此,该病毒以19作为后缀表示。这种最初作为流行病开始的疾病很快就开始了它的普遍形式,并在全球范围内成为一种严重的流行病。当前的文章试图理解COVID-19的各个方面,也被称为新型冠状病毒,人们经常将其与2002年在中国爆发的SARS进行比较。本文还试图揭示政府和私营企业采取的各种措施,以遏制传染的强度。本文着重介绍了新型冠状病毒病的临床症状和流行病学特征,并简要介绍了遏制新型冠状病毒病快速传播的可能措施。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Loss of control of the pandemic during vaccination in Uruguay Nodular periorbital dirofilariasis in a child in Romania: case report Acinetobacter baumannii, a global health-threatening bacterium: a short review Pandemic parameters: history revisited Nasal carriage of Staphylococcus aureus among a healthy suburban population: genotypic diversity and frequency of pathogenicity genes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1